Literature DB >> 12948602

Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage.

Bruno Sergi1, Aldo Ferraresi, Diana Troiani, Gaetano Paludetti, Anna Rita Fetoni.   

Abstract

The aim of the present study was to investigate both vestibular and cochlear cisplatin toxicity. Twelve albino guinea pigs were divided into an experimental (n=8) and a control saline group (n=4) and were treated with cisplatin at a daily dose of 2.5 mg/kg for 6 consecutive days. Vestibular dysfunction was evaluated by computing the gain of the vestibular ocular reflex (VOR) evoked by stimulation in the horizontal (HVOR) and vertical (VVOR) planes. Changes in cochlear function were characterised as compound action potential threshold shifts. After the functional testing, tympanic bullae were removed and processed for morphological examination of the sensorineural epithelium. The onset of vestibular functional impairment was observed on the third day, although the VOR gain decrease was not significant. The impairment of the vestibular function progressed until the sixth day becoming statistically significant particularly at VVOR mid frequencies of stimulation. At these frequencies both macula and crista ampullaris functions are involved. Concomitantly a progressive auditory threshold shift was observed at all stimulus frequencies. The decline of the auditory function was statistically significant from the third day of treatment and it was more evident at high frequencies. Morphological observations showed a massive loss of outer hair cells and a degeneration of the organ of Corti in the basal/middle turns and only a slight loss of hair cells of the cristae ampullares and maculae. In conclusion, functional and morphological data provide evidence that the toxic effect of cisplatin is more pronounced in the organ of Corti than in the vestibular epithelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948602     DOI: 10.1016/s0378-5955(03)00142-4

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  21 in total

1.  [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].

Authors:  C-M Schmidt; E Bartholomäus; D Deuster; A Heinecke; A G Dinnesen
Journal:  HNO       Date:  2007-04       Impact factor: 1.284

Review 2.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

3.  Comparison of cochlear cell death caused by cisplatin, alone and in combination with furosemide.

Authors:  Li Xia; Zhengnong Chen; Kaiming Su; Shankai Yin; Jian Wang
Journal:  Toxicol Pathol       Date:  2013-04-02       Impact factor: 1.902

4.  Protective effects of N-acetylcysteine on noise-induced hearing loss in guinea pigs.

Authors:  A R Fetoni; M Ralli; B Sergi; C Parrilla; D Troiani; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-04       Impact factor: 2.124

5.  An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.

Authors:  K Fernandez; T Wafa; T S Fitzgerald; L L Cunningham
Journal:  Hear Res       Date:  2019-02-22       Impact factor: 3.208

Review 6.  Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Authors:  Penelope R Brock; Kristin R Knight; David R Freyer; Kathleen C M Campbell; Peter S Steyger; Brian W Blakley; Shahrad R Rassekh; Kay W Chang; Brian J Fligor; Kaukab Rajput; Michael Sullivan; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

Review 7.  Ototoxicity in dogs and cats.

Authors:  Naoki Oishi; Andra E Talaska; Jochen Schacht
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-10-10       Impact factor: 2.093

8.  Cisplatin exposure damages resident stem cells of the mammalian inner ear.

Authors:  Eric L Slattery; Kazuo Oshima; Stefan Heller; Mark E Warchol
Journal:  Dev Dyn       Date:  2014-06-25       Impact factor: 3.780

9.  The role of thiamine pyrophosphate in prevention of cisplatin ototoxicity in an animal model.

Authors:  Ozan Kuduban; Cuneyt Kucur; Ebru Sener; Halis Suleyman; Fatih Akcay
Journal:  ScientificWorldJournal       Date:  2013-09-16

10.  A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.

Authors:  C J Tian; Y J Kim; S W Kim; H J Lim; Y S Kim; Y-H Choung
Journal:  Cell Death Dis       Date:  2013-02-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.